Dr. Rosanna Peeling
 
Director, Sexually Transmitted Diseases Diagnostics Initiatve (SDI), World Health Organization, Geneva, Switzerland

Degrees: B.Sc. (Toronto, 1969), M.Sc. (Manitoba, 1972), Ph.D (Manitoba, 1988)

Mailing Address:
London School of Hygiene & Tropical Medicine
University of London, Room 265, Clinical Research Unit, ITD
Keppel Street, London WC1E7HT, UK

Tel: 020782725292 Fax: 02076374314
E-mail: rosanna.peeling@lshtm.ac.uk

Research Interests:
sexually transmitted diseases, pathogenesis of chlamydial infections, trachoma, diagnostics

For a list of Dr. Peeling's PubMed articles, please click here

  1. Solomon A.W., Holland M.J., Burton M. J. et al. Strategy for the control of trachoma: insights from quantitative PCR. Lancet (in press).
  2. Marrie T.J., Peeling R.W., Reid T., de Carolis E. Canadian Community-acquired Pneumonia Investigators. Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur. Respir. J. 21:779-84, 2003.
  3. Caldwell H.D., Wood H., Crane D. et al. Polymorphisms in Chlamydia trachomatis tryptophan Synthase gene differentiates between genital and ocular isolates. Implications in pathogenesis and infection tropism. J. Clin. Invest. 111:1757-69, 2003.
  4. Fong I.W., Chiu B., Viira E., et al. Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques. J. Infect. Dis. 186:1469-73, 2002.
  5. Cowan F.M., Langhaug L.F., Mashungupa G.P. et al. School-based HIV prevention in Zimbabwe: feasibility and acceptibility of evaluation trials using biological outcome measures. AIDS 16:1673-78, 2002.
  6. Shang H. Chen X., Ye Q.H. et al. Pelvic inflammatory disease in the People's Republic of China: aetiology and management. Int. J. STD & AIDS 13:568-72, 2002.
  7. Wang Q.Q., Peeling R.W., Mabey D., et al. Validation of syndromic algorithm for the management of genital ulcer diseases in China. Int. J. STD & AIDS 13:469-74; 2002.
  8. Hodgins S, peeling R.W., Dery S. et al. The utility of mass screening for Chlamydia control in high prevalence communities. Sex. Transm. Inf. 78(suppl 1):164-8, 2002.
  9. Smith J.S., Munoz N., Herrero R., et al. Evidence for Chlamydia trachomatis as a Human Papillomavirus co-factor in the etiology of invasive cervical cancer in Brazil and the Philippines. J. Infect. Dis. 185:324-31, 2002.
  10. Mabey D., Peeling R.W. Rapid diagnostic tests for sexually transmitted infections. International Planned Parenthood Federation Medical Bulletin 36:1-3, 2002.
  11. Wolf K, Fischer E., Mead D., et al. The Chlamydia pneumoniae MOMP is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect. Immun. 69:3082-91, 2001.
  12. Dowell S.F., Peeling R.W., Boman J., et al. Standardizing Chlamydia pneumoniae assays:recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. 33:492-503, 2001.
Laboratory Members:
H. Wood Ph.D. student heidi_wood@hc-sc.gc.ca